Three complementary activities will be implemented:1) Baseline and repeat census of the catchment population; described in a separate protocol (IVI-ECOVA-03-WS1); 2) Enhanced surveillance for COVID-19 disease, and 3) AEFI-enhanced surveillance. The mass vaccination campaign will be conducted by the Government and is not part of this protocol.
Study Type
OBSERVATIONAL
Enrollment
3,000
Sinopharm Vaccine will be administered by the Govt as part of COVID-19vaccination campaign
Dondo Health Facility
Dondo, Mozambique
RECRUITINGProtection conferred by two completed doses of Sinopharm vaccine against confirmed COVID-19 disease
Protection conferred by two completed doses of Sinopharm vaccine against RT-PCR-confirmed COVID-19 disease measured as the reduction in risk in adults who received two completed doses of the vaccine compared to those who are not vaccinated.
Time frame: 2 years
Evaluate the effectiveness of two completed doses of the Sinopharm vaccine against severe SARS-CoV-2 infection
Evaluate the effectiveness of two completed doses of the Sinopharm vaccine against RT-PCR confirmed severe SARS-CoV-2 infection
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.